Stock lookup

Which ETFs hold Mesoblast Ltd (MSB)?

Australian biotech developing cell therapies, with a US-approved treatment for children.

16 Australian ETFs hold Mesoblast Ltd, a Health Care company from Australia. SSO has the biggest weighting at 0.76%. Across these funds, Australian ETF investors own about $53m of Mesoblast Ltd.

ETFs holding it16
Highest weight0.8%
Largest holder by sizeVAS
Held via ETFs$53m

Look up another stock β†’

Top 10 by weight

The ETFs with the most Mesoblast Ltd

Share of each fund invested in Mesoblast Ltd, from issuers' published holdings.

All 16 ETFs that hold Mesoblast Ltd, ranked by weight

Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.

Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Mesoblast Ltd.

Common questions

Which ETF has the most Mesoblast Ltd?

SSO (State Street SPDR S&P/ASX Small Ordinaries ETF) has the highest weighting, with 0.76% of the fund in Mesoblast Ltd.

What is the cheapest ETF that holds Mesoblast Ltd?

Of the ETFs where Mesoblast Ltd is at least 1% of the fund, OZXX has the lowest fee at 0.25% a year, with 0.29% in Mesoblast Ltd.

How much Mesoblast Ltd do I own with $10,000 in VAS?

About $7. VAS is the largest ETF that holds Mesoblast Ltd, and Mesoblast Ltd makes up 0.07% of it.

How many Australian ETFs hold Mesoblast Ltd?

16 ETFs listed on the ASX or TMX Australia hold Mesoblast Ltd, based on issuers' published holdings.